 | • レポートコード：20QY06-04386 • 出版社/出版日：QYResearch / 2020年6月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、139ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、レボチロキシンのグローバル市場について種類別（固形型スライス、注射用ボトル入り）、用途別（病院、薬局、その他医療機関）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・レボチロキシン市場の概要 ・世界の主要地域別レボチロキシン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のレボチロキシン市場規模2015-2026：種類別（固形型スライス、注射用ボトル入り） ・世界のレボチロキシン市場規模2015-2026：用途別（病院、薬局、その他医療機関） ・レボチロキシンの北米市場規模2015-2020 ・レボチロキシンのヨーロッパ市場規模2015-2020 ・レボチロキシンの中国市場規模2015-2020 ・レボチロキシンの日本市場規模2015-2020 ・レボチロキシンの東南アジア市場規模2015-2020 ・レボチロキシンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Abbott Ltd、Alara Pharm (Sandoz)、Forest (Actavis)、Merck Serono、Piramal Healthcare、Mylan、KING PHARMS R AND D、Jerome Stevens） ・レボチロキシンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・レボチロキシンの市場動向・機会・課題 ・調査の結論 |
Levothyroxine is used to treat low thyroid activity and to treat or suppress different types of goiters.
Levothyroxine is a replacement for a hormone normally produced by your thyroid gland to regulate the body’s energy and metabolism. Levothyroxine is given when the thyroid does not produce enough of this hormone on its own.
Levothyroxine treats hypothyroidism (low thyroid hormone). It is also used to treat or prevent goiter (enlarged thyroid gland), which can be caused by hormone imbalances, radiation treatment, surgery, or cancer.
At present, United States market is mainly occupied by own brands. The domestic enterprise technology still keeps leading level.
Market Analysis and Insights: Global Levothyroxine Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Levothyroxine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Levothyroxine industry.
Based on our recent survey, we have several different scenarios about the Levothyroxine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Levothyroxine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Levothyroxine Scope and Market Size
The global Levothyroxine market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Levothyroxine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Levothyroxine market is segmented into
Slice in solid
In bottles for injection
Segment by Application, the Levothyroxine market is segmented into
Hospitals
Chemist’s shops
Other medical institutions
The Levothyroxine market is analysed and market size information is provided by regions (countries). Segment by Application, the Levothyroxine market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Levothyroxine Market Share Analysis
Levothyroxine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Levothyroxine business, the date to enter into the Levothyroxine market, Levothyroxine product introduction, recent developments, etc.
The major vendors covered:
Abbott Ltd
Alara Pharm (Sandoz)
Forest (Actavis)
Merck Serono
Piramal Healthcare
Mylan
KING PHARMS R AND D
Jerome Stevens
1 Levothyroxine Market Overview
1.1 Levothyroxine Product Scope
1.2 Levothyroxine Segment by Type
1.2.1 Global Levothyroxine Sales by Type (2020-2026)
1.2.2 Slice in solid
1.2.3 In bottles for injection
1.3 Levothyroxine Segment by Application
1.3.1 Global Levothyroxine Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Chemist’s shops
1.3.4 Other medical institutions
1.4 Levothyroxine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Levothyroxine Sales Growth Rate (2015-2026)
1.4.2 Global Levothyroxine Revenue and Growth Rate (2015-2026)
1.4.3 Global Levothyroxine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Levothyroxine Industry Impact
1.5.1 How the Covid-19 is Affecting the Levothyroxine Industry
1.5.1.1 Levothyroxine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Levothyroxine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Levothyroxine Players to Combat Covid-19 Impact
2 Levothyroxine Estimate and Forecast by Region
2.1 Global Levothyroxine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Levothyroxine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Levothyroxine Sales Market Share by Region (2015-2020)
2.2.2 Global Levothyroxine Revenue Market Share by Region (2015-2020)
2.3 Global Levothyroxine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Levothyroxine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Levothyroxine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Levothyroxine Estimates and Projections (2015-2026)
2.4.2 Europe Levothyroxine Estimates and Projections (2015-2026)
2.4.3 China Levothyroxine Estimates and Projections (2015-2026)
2.4.4 Japan Levothyroxine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Levothyroxine Estimates and Projections (2015-2026)
2.4.6 India Levothyroxine Estimates and Projections (2015-2026)
3 Global Levothyroxine Competition Landscape by Players
3.1 Global Top Levothyroxine Players by Sales (2015-2020)
3.2 Global Top Levothyroxine Players by Revenue (2015-2020)
3.3 Global Levothyroxine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Levothyroxine as of 2019)
3.4 Global Levothyroxine Average Price by Company (2015-2020)
3.5 Manufacturers Levothyroxine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Levothyroxine Players (Opinion Leaders)
4 Global Levothyroxine Market Size by Type
4.1 Global Levothyroxine Historic Market Review by Type (2015-2020)
4.1.1 Global Levothyroxine Sales Market Share by Type (2015-2020)
4.1.2 Global Levothyroxine Revenue Market Share by Type (2015-2020)
4.1.3 Global Levothyroxine Price by Type (2014-2020)
4.2 Global Levothyroxine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Levothyroxine Sales Forecast by Type (2021-2026)
4.2.2 Global Levothyroxine Revenue Forecast by Type (2021-2026)
4.2.3 Global Levothyroxine Price Forecast by Type (2021-2026)
5 Global Levothyroxine Market Size by Application
5.1 Global Levothyroxine Historic Market Review by Application (2015-2020)
5.1.1 Global Levothyroxine Sales Market Share by Application (2015-2020)
5.1.2 Global Levothyroxine Revenue Market Share by Application (2015-2020)
5.1.3 Global Levothyroxine Price by Application (2015-2020)
5.2 Global Levothyroxine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Levothyroxine Sales Forecast by Application (2021-2026)
5.2.2 Global Levothyroxine Revenue Forecast by Application (2021-2026)
5.2.3 Global Levothyroxine Price Forecast by Application (2021-2026)
3 North America Levothyroxine Market Facts & Figures
3.2 North America Levothyroxine Sales Market Share by Company (2015-2020)
3.3 North America Levothyroxine Sales Market Share by Type (2015-2020)
3.4 North America Levothyroxine Sales Market Share by Application (2015-2020)
4 Europe Levothyroxine Market Facts & Figures
4.2 Europe Levothyroxine Sales Market Share by Company (2015-2020)
4.3 Europe Levothyroxine Sales Market Share by Type (2015-2020)
4.4 Europe Levothyroxine Sales Market Share by Application (2015-2020)
5 China Levothyroxine Market Facts & Figures
5.2 China Levothyroxine Sales Market Share by Company (2015-2020)
5.3 China Levothyroxine Sales Market Share by Type (2015-2020)
5.4 China Levothyroxine Sales Market Share by Application (2015-2020)
6 Japan Levothyroxine Market Facts & Figures
6.2 Japan Levothyroxine Sales Market Share by Company (2015-2020)
6.3 Japan Levothyroxine Sales Market Share by Type (2015-2020)
6.4 Japan Levothyroxine Sales Market Share by Application (2015-2020)
7 Southeast Asia Levothyroxine Market Facts & Figures
7.2 Southeast Asia Levothyroxine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Levothyroxine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Levothyroxine Sales Market Share by Application (2015-2020)
8 India Levothyroxine Market Facts & Figures
8.2 India Levothyroxine Sales Market Share by Company (2015-2020)
8.3 India Levothyroxine Sales Market Share by Type (2015-2020)
8.4 India Levothyroxine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Levothyroxine Business
12.1 Abbott Ltd
12.1.1 Abbott Ltd Levothyroxine Corporation Information
12.1.2 Abbott Ltd Levothyroxine Business Overview and Total Revenue
12.1.3 Abbott Ltd Levothyroxine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Abbott Ltd Levothyroxine Products Offered
12.1.5 Abbott Ltd Recent Development
12.2 Alara Pharm (Sandoz)
12.2.1 Alara Pharm (Sandoz) Levothyroxine Corporation Information
12.2.2 Alara Pharm (Sandoz) Levothyroxine Business Overview and Total Revenue
12.2.3 Alara Pharm (Sandoz) Levothyroxine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Alara Pharm (Sandoz) Levothyroxine Products Offered
12.2.5 Alara Pharm (Sandoz) Recent Development
12.3 Forest (Actavis)
12.3.1 Forest (Actavis) Levothyroxine Corporation Information
12.3.2 Forest (Actavis) Levothyroxine Business Overview and Total Revenue
12.3.3 Forest (Actavis) Levothyroxine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Forest (Actavis) Levothyroxine Products Offered
12.3.5 Forest (Actavis) Recent Development
12.4 Merck Serono
12.4.1 Merck Serono Levothyroxine Corporation Information
12.4.2 Merck Serono Levothyroxine Business Overview and Total Revenue
12.4.3 Merck Serono Levothyroxine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck Serono Levothyroxine Products Offered
12.4.5 Merck Serono Recent Development
12.5 Piramal Healthcare
12.5.1 Piramal Healthcare Levothyroxine Corporation Information
12.5.2 Piramal Healthcare Levothyroxine Business Overview and Total Revenue
12.5.3 Piramal Healthcare Levothyroxine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Piramal Healthcare Levothyroxine Products Offered
12.5.5 Piramal Healthcare Recent Development
12.6 Mylan
12.6.1 Mylan Levothyroxine Corporation Information
12.6.2 Mylan Levothyroxine Business Overview and Total Revenue
12.6.3 Mylan Levothyroxine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mylan Levothyroxine Products Offered
12.6.5 Mylan Recent Development
12.7 KING PHARMS R AND D
12.7.1 KING PHARMS R AND D Levothyroxine Corporation Information
12.7.2 KING PHARMS R AND D Levothyroxine Business Overview and Total Revenue
12.7.3 KING PHARMS R AND D Levothyroxine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 KING PHARMS R AND D Levothyroxine Products Offered
12.7.5 KING PHARMS R AND D Recent Development
12.8 Jerome Stevens
12.8.1 Jerome Stevens Levothyroxine Corporation Information
12.8.2 Jerome Stevens Levothyroxine Business Overview and Total Revenue
12.8.3 Jerome Stevens Levothyroxine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Jerome Stevens Levothyroxine Products Offered
12.8.5 Jerome Stevens Recent Development
13 Levothyroxine Manufacturing Cost Analysis
13.1 Levothyroxine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Levothyroxine
13.4 Levothyroxine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Levothyroxine Distributors List
14.3 Levothyroxine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Levothyroxine Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Levothyroxine Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Levothyroxine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Levothyroxine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Levothyroxine Players to Combat Covid-19 Impact
Table 8. Global Market Levothyroxine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Levothyroxine Sales (K MT) by Region (2015-2020)
Table 10. Global Levothyroxine Sales Market Share by Region (2015-2020)
Table 11. Global Levothyroxine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Levothyroxine Revenue Share by Region (2015-2020)
Table 13. Global Levothyroxine Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global Levothyroxine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Levothyroxine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Levothyroxine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Levothyroxine (K MT) of Key Companies (2015-2020)
Table 18. Global Levothyroxine Sales Share by Company (2015-2020)
Table 19. Global Levothyroxine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Levothyroxine Revenue Share by Company (2015-2020)
Table 21. Global Levothyroxine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Levothyroxine as of 2019)
Table 22. Global Levothyroxine Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Levothyroxine Manufacturing Sites and Area Served
Table 24. Manufacturers Levothyroxine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Levothyroxine Players
Table 27. Global Levothyroxine Sales (K MT) by Type (2015-2020)
Table 28. Global Levothyroxine Sales Share by Type (2015-2020)
Table 29. Global Levothyroxine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Levothyroxine Price (K MT) by Type (2015-2020)
Table 31. Global Levothyroxine Sales Share by Type (2021-2026)
Table 32. Global Levothyroxine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Levothyroxine Revenue Share by Type (2021-2026)
Table 34. Global Levothyroxine Price (K MT) by Type (2021-2026)
Table 35. Global Levothyroxine Sales (K MT) by Application (2015-2020)
Table 36. Global Levothyroxine Sales Share by Application (2015-2020)
Table 37. Global Levothyroxine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Levothyroxine Price (K MT) by Application (2015-2020)
Table 39. Global Levothyroxine Sales (K MT) by Application (2021-2026)
Table 40. Global Levothyroxine Sales Share by Application (2021-2026)
Table 41. Global Levothyroxine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Levothyroxine Revenue Share by Application (2021-2026)
Table 43. Global Levothyroxine Price (K MT) by Application (2021-2026)
Table 44. United States Levothyroxine Sales (K MT) by Company (2015-2020)
Table 45. United States Levothyroxine Sales Market Share by Company (2015-2020)
Table 46. United States Levothyroxine Sales (K MT) by Type (2015-2020)
Table 47. United States Levothyroxine Sales Market Share by Type (2015-2020)
Table 48. United States Levothyroxine Sales (K MT) by Application (2015-2020)
Table 49. United States Levothyroxine Sales Market Share by Application (2015-2020)
Table 50. Europe Levothyroxine Sales (K MT) by Company (2015-2020)
Table 51. Europe Levothyroxine Sales Market Share by Company (2015-2020)
Table 52. Europe Levothyroxine Sales (K MT) by Type (2015-2020)
Table 53. Europe Levothyroxine Sales Market Share by Type (2015-2020)
Table 54. Europe Levothyroxine Sales (K MT) by Application (2015-2020)
Table 55. Europe Levothyroxine Sales Market Share by Type (2015-2020)
Table 56. China Levothyroxine Sales (K MT) by Company (2015-2020)
Table 57. China Levothyroxine Sales Market Share by Company (2015-2020)
Table 58. China Levothyroxine Sales (K MT) by Type (2015-2020)
Table 59. China Levothyroxine Sales Market Share by Type (2015-2020)
Table 60. China Levothyroxine Sales (K MT) by Application (2015-2020)
Table 61. China Levothyroxine Sales Market Share by Application (2015-2020)
Table 62. Japan Levothyroxine Sales (K MT) by Company (2015-2020)
Table 63. Japan Levothyroxine Sales Market Share by Company (2015-2020)
Table 64. Japan Levothyroxine Sales (K MT) by Type (2015-2020)
Table 65. Japan Levothyroxine Sales Market Share by Type (2015-2020)
Table 66. Japan Levothyroxine Sales (K MT) by Application (2015-2020)
Table 67. Japan Levothyroxine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Levothyroxine Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia Levothyroxine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Levothyroxine Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia Levothyroxine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Levothyroxine Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia Levothyroxine Sales Market Share by Application (2015-2020)
Table 74. India Levothyroxine Sales (K MT) by Company (2015-2020)
Table 75. India Levothyroxine Sales Market Share by Company (2015-2020)
Table 76. India Levothyroxine Sales (K MT) by Type (2015-2020)
Table 77. India Levothyroxine Sales Market Share by Type (2015-2020)
Table 78. India Levothyroxine Sales (K MT) by Application (2015-2020)
Table 79. India Levothyroxine Sales Market Share by Application (2015-2020)
Table 80. Abbott Ltd Corporation Information
Table 81. Abbott Ltd Description and Business Overview
Table 82. Abbott Ltd Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Abbott Ltd Levothyroxine Product
Table 84. Abbott Ltd Recent Development
Table 85. Alara Pharm (Sandoz) Corporation Information
Table 86. Alara Pharm (Sandoz) Description and Business Overview
Table 87. Alara Pharm (Sandoz) Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Alara Pharm (Sandoz) Levothyroxine Product
Table 89. Alara Pharm (Sandoz) Recent Development
Table 90. Forest (Actavis) Corporation Information
Table 91. Forest (Actavis) Description and Business Overview
Table 92. Forest (Actavis) Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Forest (Actavis) Levothyroxine Product
Table 94. Forest (Actavis) Recent Development
Table 95. Merck Serono Corporation Information
Table 96. Merck Serono Description and Business Overview
Table 97. Merck Serono Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Merck Serono Levothyroxine Product
Table 99. Merck Serono Recent Development
Table 100. Piramal Healthcare Corporation Information
Table 101. Piramal Healthcare Description and Business Overview
Table 102. Piramal Healthcare Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Piramal Healthcare Levothyroxine Product
Table 104. Piramal Healthcare Recent Development
Table 105. Mylan Corporation Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Mylan Levothyroxine Product
Table 109. Mylan Recent Development
Table 110. KING PHARMS R AND D Corporation Information
Table 111. KING PHARMS R AND D Description and Business Overview
Table 112. KING PHARMS R AND D Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. KING PHARMS R AND D Levothyroxine Product
Table 114. KING PHARMS R AND D Recent Development
Table . Jerome Stevens Corporation Information
Table . Jerome Stevens Levothyroxine Sales (K MT), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Jerome Stevens Description and Business Overview
Table . Jerome Stevens Levothyroxine Product
Table . Jerome Stevens Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Levothyroxine Distributors List
Table 123. Levothyroxine Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Levothyroxine Product Picture
Figure 2. Global Levothyroxine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Levothyroxine Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Chemist's shops Examples
Figure 8. Other medical institutions Examples
Figure 9. Global Levothyroxine Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Levothyroxine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Levothyroxine Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Levothyroxine Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Levothyroxine Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Levothyroxine Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Levothyroxine Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Levothyroxine Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Levothyroxine Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Levothyroxine Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Levothyroxine Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Levothyroxine Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Levothyroxine Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Levothyroxine Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Levothyroxine Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Levothyroxine Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Levothyroxine Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Levothyroxine Players Market Share by Revenue in Levothyroxine 2015 & 2019
Figure 27. Levothyroxine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Levothyroxine Revenue Share by Type (2015-2020)
Figure 29. Global Levothyroxine Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Levothyroxine Revenue Share by Application (2015-2020)
Figure 31. Global Levothyroxine Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Levothyroxine Sales Market Share by Type in 2019
Figure 33. United States Levothyroxine Sales Market Share by Type in 2019
Figure 34. Europe Levothyroxine Sales Market Share by Company in 2019
Figure 35. Europe Levothyroxine Sales Market Share by Type in 2019
Figure 36. Europe Levothyroxine Sales Market Share by Application in 2019
Figure 37. China Levothyroxine Sales Market Share by Company in 2019
Figure 38. China Levothyroxine Sales Market Share by Type in 2019
Figure 39. China Levothyroxine Sales Market Share by Application in 2019
Figure 40. Japan Levothyroxine Sales Market Share by Company in 2019
Figure 41. Japan Levothyroxine Sales Market Share by Type in 2019
Figure 42. Japan Levothyroxine Sales Market Share by Application in 2019
Figure 43. Southeast Asia Levothyroxine Sales Market Share by Company in 2019
Figure 44. Southeast Asia Levothyroxine Sales Market Share by Type in 2019
Figure 45. Southeast Asia Levothyroxine Sales Market Share by Application in 2019
Figure 46. India Levothyroxine Sales Market Share by Company in 2019
Figure 47. India Levothyroxine Sales Market Share by Type in 2019
Figure 48. India Levothyroxine Sales Market Share by Application in 2019
Figure 49. Abbott Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Alara Pharm (Sandoz) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Forest (Actavis) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Merck Serono Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Piramal Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. KING PHARMS R AND D Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Jerome Stevens Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Key Raw Materials Price Trend
Figure 58. Manufacturing Cost Structure of Levothyroxine
Figure 59. Manufacturing Process Analysis of Levothyroxine
Figure 60. Levothyroxine Industrial Chain Analysis
Figure 61. Channels of Distribution
Figure 62. Distributors Profiles
Figure 63. Porter's Five Forces Analysis
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
注射用マムシ由来凝血促進剤の世界市場レポート2020 Market Analysis and Insights: Global Haemocoagulase Agkistrodon for Injection Market The global Haemocoagulase Agkistrodon for Injection market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Haemocoagulase Agki…- 湯たんぽの世界市場レポート2020 A recently published report by QY Research titled Global Hot Water Bottles Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …
- PEボトルの世界市場レポート2020 Market Analysis and Insights: Global PE Bottles Market The global PE Bottles market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global PE Bottles Scope and Market Size The global PE Bottles market is segmented by T…
- ペットボトル＆コンテナの世界市場レポート2020 Plastic Bottles & Containers is a kind of Bottles & Containers made of plastic, such as PET, PP, HDPE, LDPE, etc. The Plastic Bottles & Containers consumption volume was 3320.22 billion units in 2017 and is expected to reach 3487.5 billion units in 2018 and 4430.62 billion units in 2023, growing at …
- PETブロー成形ボトルの世界市場レポート2020 A recently published report by QY Research titled Global PET Blow Molded Bottles Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides acc…